The efficacy of bevacizumab combined with chemotherapy in the treatment of postoperative patients with oligometastatic colorectal cancer and its impact on mpfs median progression-free survival
The Journal of Practical Medicine
2026 Vol.42 (5): 750-758
[Abstract]
(8)
[PDF 811 KB]
(6)
